208 related articles for article (PubMed ID: 23600579)
1. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update.
LeBlanc JG; Aubry C; Cortes-Perez NG; de Moreno de LeBlanc A; Vergnolle N; Langella P; Azevedo V; Chatel JM; Miyoshi A; Bermúdez-Humarán LG
FEMS Microbiol Lett; 2013 Jul; 344(1):1-9. PubMed ID: 23600579
[TBL] [Abstract][Full Text] [Related]
2. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
3. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
Wang M; Gao Z; Zhang Y; Pan L
Appl Microbiol Biotechnol; 2016 Jul; 100(13):5691-701. PubMed ID: 27154346
[TBL] [Abstract][Full Text] [Related]
4. Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
Wyszyńska A; Kobierecka P; Bardowski J; Jagusztyn-Krynicka EK
Appl Microbiol Biotechnol; 2015 Apr; 99(7):2967-77. PubMed ID: 25750046
[TBL] [Abstract][Full Text] [Related]
5. Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges.
Villena J; Oliveira ML; Ferreira PC; Salva S; Alvarez S
Int Immunopharmacol; 2011 Nov; 11(11):1633-45. PubMed ID: 21708293
[TBL] [Abstract][Full Text] [Related]
6. Engineering lactococci and lactobacilli for human health.
Bermúdez-Humarán LG; Aubry C; Motta JP; Deraison C; Steidler L; Vergnolle N; Chatel JM; Langella P
Curr Opin Microbiol; 2013 Jun; 16(3):278-83. PubMed ID: 23850097
[TBL] [Abstract][Full Text] [Related]
7. Probiotics: multifarious oral vaccine against infectious traumas.
Amdekar S; Dwivedi D; Roy P; Kushwah S; Singh V
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):299-306. PubMed ID: 20100178
[TBL] [Abstract][Full Text] [Related]
8. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
Shi D; Song Y; Li YJ
Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
[TBL] [Abstract][Full Text] [Related]
9. Lactic acid bacteria as live vaccines.
Mercenier A; Müller-Alouf H; Grangette C
Curr Issues Mol Biol; 2000 Jan; 2(1):17-25. PubMed ID: 11464916
[TBL] [Abstract][Full Text] [Related]
10. Genetically modified probiotics in foods.
Ahmed FE
Trends Biotechnol; 2003 Nov; 21(11):491-7. PubMed ID: 14573362
[TBL] [Abstract][Full Text] [Related]
11. Lactic acid bacteria as oral delivery systems for biomolecules.
Berlec A; Ravnikar M; Strukelj B
Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237
[TBL] [Abstract][Full Text] [Related]
12. Lactic acid bacteria and their effect on the immune system.
Perdigón G; Fuller R; Raya R
Curr Issues Intest Microbiol; 2001 Mar; 2(1):27-42. PubMed ID: 11709854
[TBL] [Abstract][Full Text] [Related]
13. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines.
Mota RM; Moreira JL; Souza MR; Horta MF; Teixeira SM; Neumann E; Nicoli JR; Nunes AC
BMC Biotechnol; 2006 Jan; 6():2. PubMed ID: 16396687
[TBL] [Abstract][Full Text] [Related]
14. Vaginal lactic acid bacteria in the mare: evaluation of the probiotic potential of native Lactobacillus spp. and Enterococcus spp. strains.
Fraga M; Perelmuter K; Delucchi L; Cidade E; Zunino P
Antonie Van Leeuwenhoek; 2008; 93(1-2):71-8. PubMed ID: 17588124
[TBL] [Abstract][Full Text] [Related]
15. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.
Levit R; Cortes-Perez NG; de Moreno de Leblanc A; Loiseau J; Aucouturier A; Langella P; LeBlanc JG; Bermúdez-Humarán LG
Gut Microbes; 2022; 14(1):2110821. PubMed ID: 35960855
[TBL] [Abstract][Full Text] [Related]
16. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the properties of human- and dairy-derived probiotics for prevention of infectious diseases in fish.
Nikoskelainen S; Salminen S; Bylund G; Ouwehand AC
Appl Environ Microbiol; 2001 Jun; 67(6):2430-5. PubMed ID: 11375147
[TBL] [Abstract][Full Text] [Related]
18. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.
Bermúdez-Humarán LG; Kharrat P; Chatel JM; Langella P
Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S4. PubMed ID: 21995317
[TBL] [Abstract][Full Text] [Related]
19. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
[TBL] [Abstract][Full Text] [Related]
20. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
